Megafine Pharma (P) Ltd.

About Megafine Pharma (P) Ltd.

MEGAFINE offering Innovative & Integrated API solutions is USFDA, EU-GMP,Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA & Mexico-COFEPRIS inspected manufacturer of high quality APIs & Intermediates to Innovators and Generic companies having 26 US-DMFs, 6 CEPs and 250+ global regulatory filings. To support its rapid growth, we have recently commissioned a NEW API plant with five production block at our Vapi site. RECENTLY VALIDATED: Ambrisentan,Apixaban, Lurasidone, Mirabegron, Rivaroxaban & Teriflunomide, Vortioxetine. NEW DEVELOPMENT: Apremilast, Brexpiprazole, Cariprazine, ...

  • IN
  • 2015
    On CPHI since
  • 1 - 24
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Contact info
  • Sethna, 4th Floor, 55 Maharshi Karve Road, Marine Lines, Mumbai, India
Meet us at

CPHI Middle East 2024

Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
10 Dec 2024 - 12 Dec 2024

Products from Megafine Pharma (P) Ltd. (5)

  • Ambrisentan

    Product Ambrisentan

    APIbrhrbrThis product is used as an intermediate for Clopidogrel. Contact us for more information.
  • Apixaban

    Product Apixaban

    APIbrhrbrThis product is used as an intermediate for Cinacalcet. Contact us for more information.
  • Apremilast

    Product Apremilast

    APIbrhrbrThis product is used as an intermediate for Solifenacin. Contact us for more information.
  • Asenapine Maleate

    Product Asenapine Maleate

    APIbrhrbrIt is used as an intermediate for Darifenacin. Contact us for more information.
  • Bosentan Monohydrate

    Product Bosentan Monohydrate

    APIbrhrbrThis product is used as an intermediate for Sitagliptin. Contact us for more information.